Loading...
Market
Story
NVIDIA Study Shows Eye-AD's Non-Invasive AI Screening Enhances Alzheimer's Detection and Healthcare Solutions
Nov 23, 2024, 11:45 AM
Recent advancements in artificial intelligence (AI) are significantly impacting healthcare, particularly in the early detection of diseases and treatment personalization. A study by NVIDIA has revealed that retinal scans developed by Eye-AD can detect early signs of Alzheimer's disease through a non-invasive and rapid screening method. This innovation offers promising potential for timely interventions. Additionally, various AI applications are being explored to enhance patient care in areas such as kidney disease management and infection treatment, particularly in combating antimicrobial resistance. Companies like AiMinds are leading these efforts, aiming to transform healthcare delivery and improve diagnostic accuracy. Overall, AI's integration into healthcare is paving the way for more efficient, accurate, and accessible medical solutions.
View original story
Similar markets
Epic Systems • 25%
Cerner • 25%
Allscripts • 25%
Other • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Kaiser Permanente • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Epic Systems • 25%
Cerner • 25%
Allscripts • 25%
Other • 25%
0-10 • 25%
11-50 • 25%
51-100 • 25%
More than 100 • 25%
0-10 providers • 25%
11-20 providers • 25%
21-30 providers • 25%
More than 30 providers • 25%
0-5 • 25%
6-10 • 25%
11-15 • 25%
16 or more • 25%
Yes • 50%
No • 50%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Kaiser Permanente • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
None of these • 25%
Only in the US • 25%
In the US and Europe • 25%
In the US, Europe, and Asia • 25%
Globally • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Johns Hopkins • 25%
Other • 25%